Abstract

Current paradigms suggest that two macrophage subsets, termed M1 and M2, are involved in inflammation and host defense. While the distinct functions of M1 and M2 macrophages have been intensively studied - the former are considered proinflammatory and the latter antiinflammatory - the determinants of their speciation are incompletely understood. Here we report our studies that identify Krüppel-like factor 4 (KLF4) as a critical regulator of macrophage polarization. Macrophage KLF4 expression was robustly induced in M2 macrophages and strongly reduced in M1 macrophages, observations that were recapitulated in human inflammatory paradigms in vivo. Mechanistically, KLF4 was found to cooperate with Stat6 to induce an M2 genetic program and inhibit M1 targets via sequestration of coactivators required for NF-κB activation. KLF4-deficient macrophages demonstrated increased proinflammatory gene expression, enhanced bactericidal activity, and altered metabolism. Furthermore, mice bearing myeloid-specific deletion of KLF4 exhibited delayed wound healing and were predisposed to developing diet-induced obesity, glucose intolerance, and insulin resistance. Collectively, these data identify KLF4 as what we believe to be a novel regulator of macrophage polarization.

Keywords

KrüppelMacrophage polarizationMacrophageCell biologyBiologyTranscription factorGenetics

Affiliated Institutions

Related Publications

Macrophage M1/M2 polarization

Macrophages can be affected by a variety of factors to change their phenotype and thus affect their function. Activated macrophages are usually divided into two categories, M1-l...

2020 European Journal of Pharmacology 2126 citations

Publication Info

Year
2011
Type
article
Volume
121
Issue
7
Pages
2736-2749
Citations
729
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

729
OpenAlex

Cite This

Xudong Liao, Nikunj Sharma, Fehmida Kapadia et al. (2011). Krüppel-like factor 4 regulates macrophage polarization. Journal of Clinical Investigation , 121 (7) , 2736-2749. https://doi.org/10.1172/jci45444

Identifiers

DOI
10.1172/jci45444